Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), (NASDAQ: CYCCP) today announced that the Company received a written ruling from the NASDAQ Hearings ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE